« PreviousNext »Seminars in Arthritis and Rheumatism
Volume 39, Issue 2 , Pages 123-131, October 2009
Volume 39, Issue 2 , Pages 123-131, October 2009
Treatment with Infliximab plus Methotrexate Improves Anemia in Patients with Rheumatoid Arthritis Independent of Improvement in Other Clinical Outcome Measures—A Pooled Analysis from Three Large, Multicenter, Double-Blind, Randomized Clinical Trials
To access this article, please choose from the options below
This research was supported by Centocor, Inc., Malvern, PA, USA, a subsidiary of Johnson & Johnson, New Brunswick, NJ. Drs. Doyle, Rahman, Han, and Han are employees of Centocor, Inc. and own stock in Johnson and Johnson. Drs. Giles, Bingham, and Bathon received consulting fees or research grants from Centocor, Inc.
PII: S0049-0172(08)00134-0
doi:10.1016/j.semarthrit.2008.08.002
© 2008 Elsevier Inc. All rights reserved.
« PreviousNext »Seminars in Arthritis and Rheumatism
Volume 39, Issue 2 , Pages 123-131, October 2009
Volume 39, Issue 2 , Pages 123-131, October 2009
